Singapore presents great opportunities for the adoption of technology in healthcare and is open for investments
NATCO is the first company in India to have received its registration approval given by Central Insecticide Board & Registration Committee (CIB&RC) for indigenous manufacture of Chlorantraniliprole
Dolomite Bio scientist demonstrating pipetting into the Nadia Go
Expanding precision medicine, ARTIS icono is designed to enable a wide procedure mix in a single interventional suite
Olympus Corp was the market leader for endoscopy devices, accounting for around 23% of the global market in 2021.
Sugammadex is indicated for the reversal of neuromuscular blockade induced by rocuronium bromide and vecuronium bromide in adults undergoing surgery
The policy aspires to reduce cost of logistics in India to be comparable to global benchmarks by 2030
The drug will be manufactured at the group’s formulation manufacturing facility at Ahmedabad SEZ, India
The Department of Health and Family Welfare updated the preparedness for transition to licensing of Class-A and Class-B medical devices with effect from 1st October, 2022 under Medical Devices Rules 2017
Cariprazine is an atypical antipsychotic indicated for the treatment of schizophrenia and acute treatment of manic or mixed episodes associated with bipolar I disorder
Subscribe To Our Newsletter & Stay Updated
